Public Policy Resources

Community Letter in Support of the DIVERSE Trials Act (H.R. 5030/S. 2706)

November 17, 2021

ACS CAN and more than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress urging them to pass the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act into law. The legislation would allow trial sponsors to reimburse patients for non-medical costs associated with their trial participation, such as travel, parking, food, or lodging; allow sponsors to provide patients with technology necessary to facilitate remote participation in clinical trials; and require the Department of Health and Human Services (HHS) to create guidance on the use of decentralized trials to increase trial diversity.

PDF icon Download DIVERSE Trials Act Community Letter

Related Resources

Advocating to Eliminate Breast Cancer Disparities

July 7, 2023

Our ability to continue to make progress against cancer relies heavily on eliminating inequities that exist in breast cancer prevention and treatment. That is why ACS CAN advocates for policies to reduce the disparities in breast cancer by improving access to prevention and early detection services, patient navigation services, insurance coverage, in-network facilities, and clinical trials.

Read more

ACS CAN Comments on DACA proposed rule

June 23, 2023

Access to care for those who are uninsured not only ensures that serious diseases like cancer can be detected and treated earlier but also often means better patient outcomes and less costs to the individual and the larger health care system.

Read more